Most grade II and grade III gliomas, as well as the secondary glioblastomas that arise from these tumors, possess point mutations that affect the substrate binding site of isocitrate dehydrogenase.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback